HHS Logo U.S. Department of Health & Human Services Divider arrowNIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
CTSA Program scholar Ying Liang

CTSA Program Scholar Support Enables NIH R01 Grant

Ying Liang, M.D., Ph.D., obtained her first NIH R01 grant to fund her research on the role of a protein called latexin in preventing cancer therapy-induced stem cell damage.

Teddy Perron has been diagnosed with a mitochondrial disease.

Rare Disease Patient Profiles

Hear rare disease patients and caregivers talk about the challenges they face and how NIH’s collaborative research efforts offer hope.

UCLA research team

Seeing Clearly

CTSA Program support enables clearest-ever image of key enzyme in cancer, aging.

Doctors with students.

Streamlining Multisite Clinical Trials

NCATS SMART IRB Reliance Platform to serve as roadmap for new NIH policy.

NCATS e-newsletter displayed on a tablet

July E-Newsletter Now Available

Learn about NCATS’ new rare diseases patient video series, a possible treatment for Parkinson’s and Gaucher, a CTSA Program training success, and more.

Rare Disease Patient Profiles

Hear rare disease patients and caregivers talk about the challenges they face and how NIH’s collaborative research efforts offer hope.

Teddy Perron has been diagnosed with a mitochondrial disease.

CTSA Program Scholar Support Enables NIH R01 Grant

Ying Liang, M.D., Ph.D., obtained her first NIH R01 grant to fund her research on the role of a protein called latexin in preventing cancer therapy-induced stem cell damage.

CTSA Program scholar Ying Liang

July E-Newsletter Now Available

Learn about NCATS’ new rare diseases patient video series, a possible treatment for Parkinson’s and Gaucher, a CTSA Program training success, and more.

NCATS e-newsletter displayed on a tablet

Seeing Clearly

CTSA Program support enables clearest-ever image of key enzyme in cancer, aging.

UCLA research team

Streamlining Multisite Clinical Trials

NCATS SMART IRB Reliance Platform to serve as roadmap for new NIH policy.

Doctors with students.

More Center News

BEST Resource coverBEST Resource Glossary
This online glossary clarifies terms used in translational science and medical product development.

Assay Guidance Manual cover artAssay Guidance Manual
Use this NCATS-supported tool to develop tests for high-throughput screening projects.

  • Facebook icon
  • Twitter icon
  • YouTube icon

Director's Corner

Watch a CTSA Program Video

NCATS CTSA Program Interview

Petra Kaufmann, M.D., M.Sc., director of the NCATS Office of Rare Diseases Research and Division of Clinical Innovation, discusses how CTSA Program support is speeding the translation of research discoveries into health benefits. View the video.

Work with Us

Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.

  • NCATS Programs & Initiatives
    NCATS encourages partnerships that cross many scientific disciplines and research sectors in pursuit of translational success.
  • Small Business Opportunities
    NCATS’ small business programs help entrepreneurs develop and commercialize new translational technologies.
  • Expertise & Resources
    NCATS staff are experts in translation, and the Center’s resources support pre-clinical and clinical activities.
  • Licensing Opportunities
    NCATS makes it easy for industry and academia to interact and partner with Center laboratories and scientists.